Your browser doesn't support javascript.
loading
Herbal formula of Bushen Jianpi combined with sorafenib inhibits hepatocellular carcinoma growth by promoting cell apoptosis and blocking the cell cycle.
Zhou, Zhangjie; Liu, Xinhua; Wu, Tingting; Que, Zujue; Wu, Zhonghua; Wu, Weizhong; Fu, Shujuan; Zhang, Shiqiang; Yang, Yun; Jiang, Haiyan; Xia, Xiaoting; Lv, Junqiang; Du, Boqian; Li, Yun; Lu, Tao; Zhang, Zhihui; Zhong, Yi.
Afiliação
  • Zhou Z; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Liu X; Science and Technology Experimental Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Wu T; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Que Z; Tumor Institute of Traditional Chinese Medicine, Longhua Hospital, Shanghai 200032, China.
  • Wu Z; Science and Technology Experimental Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Wu W; Institute of Liver Cancer,Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China.
  • Fu S; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Zhang S; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Yang Y; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Jiang H; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Xia X; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Lv J; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Du B; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Li Y; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Lu T; Science and Technology Experimental Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Zhang Z; Institute of vascular disease, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
  • Zhong Y; Oncology Department, Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
J Tradit Chin Med ; 41(2): 194-202, 2021 04.
Article em En | MEDLINE | ID: mdl-33825398
Assuntos
Palavras-chave
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Tradit Chin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Tradit Chin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China